US Medical Imaging Industry Faces Transition
June 29, 2015 | PRNewswireEstimated reading time: 2 minutes
Medical imaging is a notoriously data intensive field with its volume, variety and speed of data generation multiplying every day. Conventional tools are incapable of efficiently managing such large and complex datasets; posing limits on scalability, sustainability and usability. As the U.S. medical imaging field evolves from being not only data-intensive but also data-driven, big data tools are expected to better handle medical imaging, patient records, and improve workflow efficiency, diagnostic accuracy, treatment decisions and health management.
Analysis from Frost & Sullivan, Big Data Opportunities in the US Medical Imaging Market, finds the market earned revenues of $39 million in 2014 and estimates this to reach $82 million by 2019 at a compound annual growth rate of 16 percent.
The U.S. medical imaging industry is experimenting with big data analytics solutions to measure, demonstrate and improve its value proposition. The next frontier will enhance data interoperability and data liquidity in order to translate static data into a dynamic database that gains actionable analytics and delivers care more efficiently.
"While current big data analytics applications for medical imaging are limited to descriptive analytics, such as operational performance monitoring, there are clear signs of the advent of advanced comparative benchmarking and predictive capabilities," said Frost & Sullivan Connected Health Industry Manager Natasha Gulati. "Imaging data management will also be a major area for investment as vendors design enterprise-wide solutions that allow a comprehensive view of all the data available to an organization."
Currently, there is no clear-cut definition for the right set of big data analytic solutions in the marketplace. Healthcare providers generally begin their Big Data journey with a goal or a particular use case in mind. Expanding the analytic solution in scope and functionality will be needed as both vendor and customer move along the learning curve.
The market is currently fragmented with disparate large-scale projects. Nevertheless, the standardization of best practices will gather momentum in the next few years, strengthening the functional framework.
"The future lies in the convergence of big data management and big data analytics," said Frost & Sullivan Advanced Medical Technology Health Principal Analyst Nadim Daher. "As the techniques for big data management, analytics in healthcare and medical imaging mature, their integration will spur a wave of partnerships and collaborations among different types of imaging IT vendors. This will pave the way for holistic solutions in the U.S. market."
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Suggested Items
Jaltek Forge Partnership to Target New ‘Agritech’ Business
07/26/2024 | JaltekJaltek is thrilled to announce it has signed a new partnership that will give ‘agritech’ innovators seeking contract manufacturing and electronics solutions a single point of contact.
Flex Appoints Michael Hartung as President, Chief Commercial Officer
07/26/2024 | FlexFlex announced the appointment of Michael Hartung as President, Chief Commercial Officer, effective immediately. In his expanded role, Mr. Hartung will continue to report to Flex CEO, Revathi Advaithi and lead both the Agility and Reliability segments, focusing on delivering on the long-term Flex Forward strategy and driving the adoption of the company's end-to-end services and products across targeted markets.
Amphenol Reports Record Q2 2024 Results and Announces Dividend Increase
07/26/2024 | Amphenol CorporationThe Company continues to deploy its financial strength in a variety of ways to increase shareholder value. During the quarter, the Company purchased 3.1 million shares of its common stock for $190 million and paid dividends of $132 million, resulting in total capital returned to shareholders of more than $320 million.
MKS’ Atotech and ESI Participate in Electronics Circuit Asia in Thailand
07/25/2024 | AtotechMKS Instruments announces its participation at the Electronics Circuit Asia 2024 in Thailand, July 24-26, highlighting its leading brands Atotech® and ESI® and related advances in advanced packaging, package substrate, and printed circuit board manufacturing.
NCAB Releases Interim Report, January–June 2024
07/25/2024 | NCABNet sales decreased by 12% to SEK 935.1 million (1,057.5). In USD, net sales decreased 13%. For comparable units, net sales decreased 15% in both SEK and USD.